A 77-year-old man in Minnesota is rationing his stroke-prevention medication because his Medicare drug plan dropped him over $28.80 in unpaid premiums he never knew he owed. He is one of roughly 140,000 people Wellcare quietly terminated in April. Some of them owed less than nine dollars.
The Bill Nobody Got
Here's the setup. Jude Pare and his partner Diane Tix split their year between rural Minnesota and Arizona, where they go to escape the cold. Their mail gets forwarded. According to NPR, Pare never received any notice from Wellcare that his $0-per-month drug plan premium was going up. So he didn't pay it. Because he didn't know there was anything to pay.
By the time they got back to Minnesota in April, a letter was waiting for them. Wellcare had canceled his coverage after three months of unpaid premiums totaling $28.80. Twenty-eight dollars and eighty cents. The cost of a mediocre brunch. Gone. Coverage: terminated.
Pare takes Xarelto, a blood thinner that keeps him from developing strokes, blood clots, and pulmonary embolism. 'He could bleed to death without it,' Tix told NPR. A 90-day supply costs around $1,800 even with a GoodRx coupon. Under Medicare rules, he cannot enroll in a new plan until fall enrollment, for coverage that won't begin until 2027.
140,000 People, One Very Quiet Announcement
Pare is not an isolated case. NPR reports that Wellcare terminated coverage for approximately 140,000 beneficiaries enrolled in its Value Script plan in April, according to a source with direct knowledge of the situation who wasn't authorized to speak publicly and feared workplace retaliation for doing so. Multiple state insurance officials told NPR they had heard the same figure independently.
Value Script is the bestselling stand-alone Medicare prescription drug plan in the country, with nearly 6 million customers nationwide, according to government data NPR reviewed. Its popularity is built almost entirely on one thing: it was free. Zero-dollar monthly premiums are catnip in a population that is disproportionately on fixed incomes.
But in 26 states and Washington D.C., some Value Script members who paid nothing in 2025 suddenly had a premium in 2026. And because the plan is administered by Wellcare, a subsidiary of the insurance giant Centene Corp., the communication about this change appears to have been somewhere between inadequate and completely invisible to the people it affected most.
The Grace Period That Wasn't Much of a Grace Period
Medicare drug plans are allowed to drop customers who don't pay their premiums after a two-month grace period. Wellcare extended that to three months, which sounds generous until you consider that thousands of people still had no idea they owed anything. A three-month warning doesn't help if the original notice never arrived, was buried in a massive annual booklet, or was sent to a snowbird's summer address in the middle of winter.
NPR's analysis, done in partnership with KFF Health News, found that some beneficiaries in Nevada owed as little as $8.10 for three months of premiums before they lost coverage. Eight dollars and ten cents. The cost of a large coffee drink at an airport. Gone. Coverage: terminated.
Of the 140,000 dropped, about 40,000 may qualify for immediate re-enrollment through Medicare's Extra Help program because of low income. That's roughly 100,000 people who are simply out of luck until 2027. The Centers for Medicare and Medicaid Services declined to provide plan-specific disenrollment data, telling NPR through a spokesperson that the agency does not publicly release those numbers.
Wellcare's Response Was Technically Accurate and Completely Insufficient
Centene declined to provide disenrollment numbers to NPR. What they did provide was a statement from Sarah Baiocchi, Wellcare's senior vice president for specialty and prescription drug plans, acknowledging that 'some members in our Value Script plan experienced a premium for the first time, or for the first time in several years.' She noted that all Value Script members received a CMS-required annual notice of changes in September.
That's the annual enrollment booklet. The one that arrives in September and explains changes to coverage for the following year. The one that is famously dense, confusing, and easy to ignore because every September, every Medicare plan sends one. If you're a senior managing multiple plans, multiple conditions, and a forwarded mail situation, the odds that you parsed the fine print about a new monthly premium in that booklet are not great.
Wellcare is legally in the clear here. They sent the required notice. CMS signed off on the plan. Everyone followed the rules. And 100,000 people are still going without prescription drug coverage for the rest of the year because of premiums some of them could have covered with the change in their couch cushions.
This Is Going to Happen Again
NPR reports that next year, thousands more people enrolled in zero-premium drug plans from Wellcare and other insurers across 32 states and Washington D.C. could face the exact same situation if their premiums increase for 2027. Plan changes for next year will be announced in September.
Nearly 90 percent of Medicare beneficiaries take at least one prescription drug, according to the CDC. Almost half live with four or more chronic conditions. These are not people who can just skip a medication for a year while they wait for open enrollment. For many of them, 'going without' is not an inconvenience. It is a medical emergency stretched across twelve months.
State insurance counselors and Medicare assistance programs are now scrambling to help affected beneficiaries figure out their options. The federally funded State Health Insurance Assistance Program, which offers free Medicare navigation help, is fielding calls. Some people may qualify for manufacturer assistance programs or drug discount options. But none of that is automatic, none of it is simple, and none of it is what these people signed up for when they enrolled in a plan that said $0 on the label.
The Dingo Take
Let's be clear about what happened here. A major insurance company sold the most popular Medicare drug plan in the country on the basis that it was free. Then it raised premiums on hundreds of thousands of elderly customers, many of them on fixed incomes, sent the required legal notice in a booklet that gets mailed alongside seventeen other booklets, and then quietly terminated coverage for 140,000 of them over debts as small as eight dollars. All of it was legal. All of it was within the rules. That's the part that should keep you up at night.
The Medicare prescription drug program was designed this way on purpose. Congress handed the whole thing to commercial insurers in 2003 and told them to compete for customers. Competition! Innovation! The magic of the market! What the market produced was a race to zero on premiums, followed by a quiet reset when the math stopped working, aimed at a population that is disproportionately elderly, medically complex, geographically scattered, and living on fixed incomes. Centene made over $1 billion in profit last quarter. Jude Pare is rationing blood thinners.
Nobody in this story did anything technically illegal. CMS followed its procedures. Wellcare followed its procedures. The rules were followed all the way down to 140,000 people losing coverage over coffee money. If that doesn't tell you something fundamental about who those rules were written for, nothing will.
